These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Müller C; Yang R; Park DJ; Serve H; Berdel WE; Koeffler HP Blood; 2000 Dec; 96(12):3894-9. PubMed ID: 11090075 [TBL] [Abstract][Full Text] [Related]
23. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes. Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536 [TBL] [Abstract][Full Text] [Related]
24. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo. Tomita A; Buchholz DR; Obata K; Shi YB J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076 [TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Park DJ; Vuong PT; de Vos S; Douer D; Koeffler HP Blood; 2003 Nov; 102(10):3727-36. PubMed ID: 12893766 [TBL] [Abstract][Full Text] [Related]
27. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity. Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703 [TBL] [Abstract][Full Text] [Related]
28. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [TBL] [Abstract][Full Text] [Related]
29. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells. Jo S; Lee YL; Kim S; Lee H; Chung H Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546 [TBL] [Abstract][Full Text] [Related]
30. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
31. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431 [TBL] [Abstract][Full Text] [Related]
32. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Villa R; Pasini D; Gutierrez A; Morey L; Occhionorelli M; Viré E; Nomdedeu JF; Jenuwein T; Pelicci PG; Minucci S; Fuks F; Helin K; Di Croce L Cancer Cell; 2007 Jun; 11(6):513-25. PubMed ID: 17560333 [TBL] [Abstract][Full Text] [Related]
33. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. Kamashev D; Vitoux D; De Thé H J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541 [TBL] [Abstract][Full Text] [Related]
34. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868 [TBL] [Abstract][Full Text] [Related]
35. Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia. Hattori H; Ishikawa Y; Kawashima N; Akashi A; Yamaguchi Y; Harada Y; Hirano D; Adachi Y; Miyao K; Ushijima Y; Terakura S; Nishida T; Matsushita T; Kiyoi H PLoS One; 2018; 13(10):e0204850. PubMed ID: 30289902 [TBL] [Abstract][Full Text] [Related]
36. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells]. Guo W; Wang H; Zhao W Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779 [TBL] [Abstract][Full Text] [Related]
37. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585 [TBL] [Abstract][Full Text] [Related]
38. The molecular biology of acute promyelocytic leukemia. Slack JL; Gallagher RE Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864 [TBL] [Abstract][Full Text] [Related]
39. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia. So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480 [TBL] [Abstract][Full Text] [Related]
40. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]